Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Neighbourly Pharmacy Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Neighbourly Pharmacy şirketinin toplam hissedar öz sermayesi CA$590.6M ve toplam borcu CA$263.1M olup, bu da borç-öz sermaye oranını 44.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CA$1.1B ve CA$521.8M dir. Neighbourly Pharmacy 'in FAVÖK'ü CA$13.1M faiz karşılama oranı 0.4 dur. Şirketin CA$17.5M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

44.5%

Borç/özkaynak oranı

CA$263.07m

Borç

Faiz karşılama oranı	0.4x
Nakit	CA$17.49m
Eşitlik	CA$590.65m
Toplam yükümlülükler	CA$521.83m
Toplam varlıklar	CA$1.11b

Son finansal sağlık güncellemeleri

Recent updates

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Aug 15

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Mar 22

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Feb 17

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Dec 09

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

Aug 10

News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts

Mar 21

Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?

Feb 27

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: NBLY 'nin kısa vadeli varlıkları ( CA$160.1M ) kısa vadeli yükümlülüklerini ( CA$140.5M ) aşıyor.

Uzun Vadeli Yükümlülükler: NBLY 'un kısa vadeli varlıkları ( CA$160.1M ) uzun vadeli yükümlülüklerini ( CA$381.3M ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: NBLY 'nin net borç/öz sermaye oranı ( 41.6% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: NBLY şirketinin borç/öz sermaye oranının son 5 yılda azalıp azalmadığını belirlemek için yeterli veri yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: Kârsız olan NBLY mevcut pozitif serbest nakit akışı seviyesini koruduğu takdirde 3 yıldan fazla yetecek nakit pistine sahip olacaktır.

Tahmini Nakit Akışı: NBLY kârlı değildir ancak serbest nakit akışının pozitif olması ve yılda % 26.9 oranında büyümesi nedeniyle 3 yıldan fazla bir süre yetecek nakit akışına sahiptir.

Neighbourly Pharmacy Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Neighbourly Pharmacy Inc. COM to Be Deleted from OTC Equity

Neighbourly Closes Go-Private Deal with Persistence

Recent updates

Neighbourly Pharmacy Inc. Announces CFO Changes

Neighbourly Pharmacy Inc. COM to Be Deleted from OTC Equity

Neighbourly Closes Go-Private Deal with Persistence

Third quarter 2024 earnings released: CA$0.11 loss per share (vs CA$0.20 loss in 3Q 2023)

Price target decreased by 12% to CA$18.80

Neighbourly Pharmacy Inc. Announces Executive Changes

Neighbourly Pharmacy Inc. to Report Q3, 2024 Results on Feb 13, 2024

Upcoming dividend of CA$0.045 per share at 1.0% yield

Now 22% undervalued

Neighbourly Pharmacy Inc. to Report Q2, 2024 Results on Oct 24, 2023

PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million.

New major risk - Share price stability

Upcoming dividend of CA$0.045 per share at 1.1% yield

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Forecast breakeven date pushed back to 2025

First quarter 2024 earnings released: CA$0.27 loss per share (vs CA$0.029 loss in 1Q 2023)

Neighbourly Pharmacy Inc. to Report Q1, 2024 Results on Aug 01, 2023

Upcoming dividend of CA$0.045 per share at 1.1% yield

Independent Chairman of the Board recently bought CA$599k worth of stock

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on August 3, 2023

Full year 2023 earnings released: CA$0.37 loss per share (vs CA$2.57 loss in FY 2022)

Neighbourly Pharmacy Inc. (TSX:NBLY) entered into a binding agreement to acquire Seven Pharmacies in Western Canada.

Neighbourly Pharmacy Inc. (TSX:NBLY) has entered into a binding agreement to acquire Three pharmacies in Ontario.

Neighbourly Pharmacy Inc., Annual General Meeting, Aug 01, 2023

Neighbourly Pharmacy Inc. to Report Q4, 2023 Results on Jun 08, 2023

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Upcoming dividend of CA$0.045 per share at 0.7% yield

CEO & Director recently bought CA$272k worth of stock

Forecast breakeven date pushed back to 2024

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on April 11, 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 42%

Neighbourly Pharmacy Inc. to Report Q3, 2023 Results on Feb 14, 2023

Neighbourly Pharmacy Inc. Announces CEO Changes

Neighbourly Pharmacy Inc. (TSX:NBLY) completed the acquisition of Cloverdale Pharmacy Ltd. and Steveston Health Centre Ltd. from CloudMD Software & Services Inc. (TSXV:DOC)

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

High number of new and inexperienced directors

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on December 20, 2022

Consensus forecasts updated

Neighbourly Pharmacy Inc. (TSX:NBLY) acquired Assets of a Retail Pharmacy Located in Manitoba.

Neighbourly Pharmacy Inc. (TSX:NBLY) enter into a binding agreement to acquire Two Community Pharmacies Located in British Columbia.

Consensus forecasts updated

Now 21% undervalued after recent price drop

Neighbourly Pharmacy Inc. Appoints Billy Wong as CFO to Succeed Terri Smyth

Upcoming dividend of CA$0.045 per share

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

First quarter 2023 earnings: EPS misses analyst expectations

Neighbourly Pharmacy Inc. Declares Dividend on Common Share for the First Quarter Ended June 18, 2022, Payable on September 27, 2022

Upcoming dividend of CA$0.045 per share

Neighbourly Pharmacy Inc. (TSX:NBLY) completed the acquisition of Rubicon Pharmacies Canada Inc.

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to CA$33.44

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on August 18, 2022

Neighbourly Pharmacy Inc. to Report Q1, 2023 Results on Aug 02, 2022

Neighbourly Pharmacy Inc., Annual General Meeting, Aug 02, 2022

Neighbourly Pharmacy Inc. to Report Q4, 2022 Results on Jun 23, 2022

High number of new and inexperienced directors

Neighbourly Pharmacy Inc. announced that it has received CAD 138.163875 million in funding from PCP GP, L.P.

News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts

Upcoming dividend of CA$0.045 per share

Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Neighbourly Pharmacy Inc. (TSX:NBLY) entered into an agreement to acquire one additional pharmacy in Canada.

Consensus forecasts updated

Upcoming dividend of CA$0.045 per share

Second quarter 2022 earnings released: CA$0.11 loss per share (vs CA$24.48 loss in 2Q 2021)

Upcoming dividend of CA$0.045 per share

Forecast breakeven pushed back to 2023

Full year 2021 earnings released: CA$19.88 loss per share (vs CA$5.08 loss in FY 2020)

Neighbourly Pharmacy Inc. (TSX:NBLY) acquired One Pharmacy in Canada.

Neighbourly Pharmacy Inc. has completed an IPO in the amount of CAD 175.015 million.

Finansal Durum Analizi